We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$691M
AUM Growth
+$33.1M
Cap. Flow
+$4.12M
Cap. Flow %
0.6%
Top 10 Hldgs %
30.46%
Holding
176
New
3
Increased
77
Reduced
45
Closed
8

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$2.8M
2
NVS icon
Novartis
NVS
+$1.2M
3
TWX
Time Warner Inc
TWX
+$1.18M
4
EBAY icon
eBay
EBAY
+$966K
5
FDX icon
FedEx
FDX
+$942K

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$6.22M
2
CB
CHUBB CORPORATION
CB
+$5.12M
3
HRL icon
Hormel Foods
HRL
+$1.62M
4
AMGN icon
Amgen
AMGN
+$1.08M
5
VTV icon
Vanguard Value ETF
VTV
+$658K

Sector Composition

Rank Sector Weight
1 Technology 21.72%
2 Healthcare 17.64%
3 Consumer Staples 12.99%
4 Industrials 10.45%
5 Energy 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
101
Alphabet (Google) Class C
GOOG
$4.07T
$591K 0.09%
15,860
+3,400
+27% +$122K
ABT icon
102
Abbott
ABT
$187B
$574K 0.08%
13,718
+899
+7% +$35.6K
LLY icon
103
Eli Lilly
LLY
$1.09T
$548K 0.08%
7,611
-126
-2% -$9.53K
RDS.A
104
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$546K 0.08%
11,267
– –
MCD icon
105
McDonald's
MCD
$194B
$534K 0.08%
4,250
+1,004
+31% +$120K
GOOGL icon
106
Alphabet (Google) Class A
GOOGL
$4.08T
$516K 0.07%
13,540
+400
+3% +$14.7K
FUL icon
107
H.B. Fuller
FUL
$3.07B
$513K 0.07%
12,094
– –
INTC icon
108
Intel
INTC
$435B
$500K 0.07%
15,460
– –
RTX icon
109
RTX Corp
RTX
$295B
$490K 0.07%
7,781
-294
-4% -$17.1K
FISV
110
Fiserv Inc
FISV
$28.9B
$487K 0.07%
9,498
– –
SON icon
111
Sonoco
SON
$5.99B
$469K 0.07%
9,666
– –
INCY icon
112
Incyte
INCY
$26B
$452K 0.07%
6,234
+1,860
+43% +$139K
MDVN
113
DELISTED
MEDIVATION, INC.
MDVN
$447K 0.06%
9,721
+3,800
+64% +$138K
TGT icon
114
Target
TGT
$65.5B
$439K 0.06%
5,336
-439
-8% -$33.1K
TXN icon
115
Texas Instruments
TXN
$253B
$429K 0.06%
7,466
+495
+7% +$26.3K
NVO
116
Novo Nordisk
NVO
$225B
$419K 0.06%
15,454
– –
GSK icon
117
GSK
GSK
$108B
$413K 0.06%
8,138
– –
CPB icon
118
Campbell Soup
CPB
$6.8B
$406K 0.06%
6,367
-50
-0.8% -$2.94K
REGN icon
119
Regeneron Pharmaceuticals
REGN
$72.9B
$406K 0.06%
1,127
+347
+44% +$143K
V icon
120
Visa
V
$697B
$405K 0.06%
5,292
– –
APC
121
DELISTED
Anadarko Petroleum
APC
$404K 0.06%
8,683
– –
BIIB icon
122
Biogen
BIIB
$30.4B
$403K 0.06%
1,547
– –
ISRG icon
123
Intuitive Surgical
ISRG
$130B
$403K 0.06%
6,039
-63
-1% -$3.9K
CSCO icon
124
Cisco
CSCO
$456B
$399K 0.06%
14,002
+100
+0.7% +$2.57K
BMRN icon
125
BioMarin Pharmaceuticals
BMRN
$12B
$384K 0.06%
4,659
+1,785
+62% +$145K
3 4
5
6 7

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q1 2016 Portfolio in Review

As of Q1 2016, Grandfield & Dodd held 176 positions worth $691M, up 5% from $658M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q1 2016 filing shows 3 new, 77 increased, 45 reduced and 8 closed positions. Its largest new stake was Chubb: 24,400 shares worth $2.91M. The largest sale was Williams Companies, an estimated $6.22M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Grandfield & Dodd's largest Q1 2016 buy was Chubb: 24,400 shares worth $2.91M.
  • Grandfield & Dodd added most to Novartis in Q1 2016, an estimated $1.2M increase.
  • Grandfield & Dodd's biggest Q1 2016 reduction was Hormel Foods, cutting an estimated $1.62M.
  • Grandfield & Dodd fully exited Williams Companies in Q1 2016, selling an estimated $6.22M.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $691M portfolio in Q1 2016.
  • Grandfield & Dodd opened 3 new positions and closed 8 in Q1 2016.
  • Grandfield & Dodd's portfolio value rose 5% quarter-over-quarter to $691M.

Based on Grandfield & Dodd's 13F filing for Q1 2016, filed 6 May 2016.